Curaleaf Ups Aurora Bid
Curaleaf increases its hostile takeover offer for Aurora Cannabis to $5 per share.
Anonymous
Key Points
1
Curaleaf estimates the combined company would generate nearly US$350 million in last-twelve-month adjusted EBITDA and at least US$40 million in annual cost synergies, with a pro forma market capitalization above US$3 billion.
2
The revised proposal is valued at US$324.2 million, compared with Curaleaf’s initial bid, which was valued at US$272 million.
3
Curaleaf says it developed the enhanced proposal using only publicly available information and remains willing to enter a formal due-diligence process with Aurora.
4
Curaleaf CEO Boris Jordan said the company had met with a significant portion of Aurora’s shareholders and claimed they supported the deal’s strategic rationale.
Curaleaf Holdings has raised its hostile takeover bid for Aurora Cannabis to $5 per share, offering an 86% premium over Aurora's original stock price MarketWatch. The new deal combines 0.4013 Curaleaf shares with $1 in cash per Aurora share, pushing the total offer value to $324.2 million. Curaleaf says the combined company would operate in 17 countries and generate over $1.5 billion in annual revenue The Globe and Mail.
Sweeter Deal, Same Rejection
Aurora's board has rejected both of Curaleaf's offers, arguing its standalone plan to grow its international medical-cannabis business is superior CTV News. The company refuses to grant Curaleaf due-diligence access or sit down for formal negotiations. Aurora urged shareholders to oppose the earlier bid as inadequate BNN Bloomberg.
Massive Cost Cuts and Revenue Growth
Curaleaf projects the merged company would generate $350 million in adjusted EBITDA over the last twelve months MarketWatch. The deal could unlock at least $40 million in annual cost savings through operations consolidation. A pro forma market capitalization would exceed $3 billion, making it a significant cannabis-industry consolidation The Globe and Mail.
CEO Pushes Shareholder Support Strategy
Curaleaf CEO Boris Jordan claims the company met with a large portion of Aurora shareholders who back the deal's strategic logic The Globe and Mail. Jordan developed the enhanced proposal using only public information since Aurora blocked formal due diligence. He set a December 4, 2026 deadline for the takeover, with a maximum deal value reaching $6 per share CTV News.
An Increase That Reflects Mounting Pressure
The jump from $272 million to $324.2 million in total offer value signals Curaleaf's determination to force a deal MarketWatch. By increasing the bid before Aurora granted due diligence, Curaleaf is betting shareholder pressure will eventually crack the board's resistance. The move is typical of hostile takeovers where the acquirer bypasses management to appeal directly to owners BNN Bloomberg.
Sentiment
Mostly PositiveNEGATIVENEUTRALPOSITIVE
Publishers
13
Articles
34
Reach
47
A
AnonymousAuthor
